Literature DB >> 8573406

Height and body mass index in Oslo, Norway, compared to other regions of Europe: do they explain differences in the incidence of hip fracture? European Vertebral Osteoporosis Study Group.

H E Meyer1, J A Falch, T O'Neill, A Tverdal, J Varlow.   

Abstract

Lean body stature and tallness have both been identified as risk factors for hip fracture. In this study, height and weight data from a multinational multicenter study were used to compare Oslo, which has some of the highest incidence rates of hip fracture ever reported, to other regions of Europe, with respect to height and body mass index. More than 17,000 subjects in six age strata (50-54, 55-59, 60-64, 65-69, 70-74, 75+ years) from 36 centers in 19 European countries were enrolled in the European Vertebral Osteoporosis Study (EVOS), which included standardized height and weight measurements. We found that men in Oslo were 4.3 cm taller than men in western Europe, 5.0 cm taller than men in eastern Europe, and 8.6 cm taller than men in southern Europe. Oslo women were also taller, by 2.2 cm compared to women in western Europe, 2.7 cm compared to women in eastern Europe, and 5.2 cm compared to women in southern Europe. In all age groups, except women aged 55-59 years, mean body mass index (BMI) was lowest in Oslo. Nearly twice as many had a BMI less than 22.0 kg/m2 in Oslo compared to the other regions combined (11.1% vs. 6.6% in men and 19.2% vs. 9.9% in women). This study indicates that the people of Oslo are taller and leaner than people in other regions of Europe. This may in part explain the higher incidence of hip fracture in the population of Oslo.

Entities:  

Mesh:

Year:  1995        PMID: 8573406     DOI: 10.1016/s8756-3282(95)00245-6

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  9 in total

1.  Risk factors for low bone mineral density among a large group of Norwegian women with fractures.

Authors:  L M Omland; G S Tell; S Ofjord; A Skag
Journal:  Eur J Epidemiol       Date:  2000-03       Impact factor: 8.082

2.  Compliance with external hip protectors in nursing homes in Norway.

Authors:  L Forsén; S Sandvig; A Schuller; A J Søgaard
Journal:  Inj Prev       Date:  2004-12       Impact factor: 2.399

3.  Hip fractures in France: the magnitude and perspective of the problem.

Authors:  C Baudoin; P Fardellone; B Thelot; R Juvin; V Potard; K Bean; J L Sebert
Journal:  Osteoporos Int       Date:  1996       Impact factor: 4.507

4.  Epidemiology of hip fracture in Iran: results from the Iranian Multicenter Study on Accidental Injuries.

Authors:  A Moayyeri; A Soltani; B Larijani; M Naghavi; F Alaeddini; F Abolhassani
Journal:  Osteoporos Int       Date:  2006-05-06       Impact factor: 4.507

5.  Effect of birth cohort on risk of hip fracture: age-specific incidence rates in the Framingham Study.

Authors:  Elizabeth J Samelson; Yuqing Zhang; Douglas P Kiel; Marian T Hannan; David T Felson
Journal:  Am J Public Health       Date:  2002-05       Impact factor: 9.308

6.  Bone mineral density at the hip in Norwegian women and men--prevalence of osteoporosis depends on chosen references: the Tromsø Study.

Authors:  Nina Emaus; Tone K Omsland; Luai Awad Ahmed; Guri Grimnes; Monica Sneve; Gro K Berntsen
Journal:  Eur J Epidemiol       Date:  2009-03-19       Impact factor: 8.082

7.  Association between height loss and bone loss, cumulative incidence of vertebral fractures and future quality of life: the Miyama study.

Authors:  N Yoshimura; H Kinoshita; T Takijiri; H Oka; S Muraki; A Mabuchi; H Kawaguchi; K Nakamura; T Nakamura
Journal:  Osteoporos Int       Date:  2007-10-26       Impact factor: 4.507

8.  Use of hormone replacement therapy among Danish nurses at increased risk of osteoporosis.

Authors:  Yrsa Andersen Hundrup; Henrik Thoning; Niels Kristian Rasmussen; Erik Bernhard Obel; John Philip
Journal:  Int J Behav Med       Date:  2003

9.  Ethnic differences in risk of hip fracture in Norway: a NOREPOS study.

Authors:  G Aamodt; R Renolen; T K Omsland; H E Meyer; K S Rabanal; A J Søgaard
Journal:  Osteoporos Int       Date:  2020-04-07       Impact factor: 4.507

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.